Related Reports
  • Industry Reports
  • 2021

Life Science Mid-Year Report 2021

The U.S. life science industry continues to shatter records for employment, venture capital funding and laboratory/R&D space demand and pricing. Life science employment reached a record high in March 2021, driven by biotechnology and other industry advancements. The outlook for 2021 remains positive as the national economy rebounds and capital is plentiful for expansion.

  • Policy Agenda
  • 2021

2021 Legislative and Public Policy Recap

The 2021 state legislative session was one of the most unusual sessions in history—being conducted completely virtually. Nevertheless, Life Science Washington’s public policy and lobbying team was able to work with our partners and legislators virtually to achieve all of LSW’s legislative goals for the session. We were able to obtain funding for new life […]

  • COVID-19
  • 2021

Update to Vaccination Eligibility Guidance Announced Last Week for Life Science Employees In Washington State

Last week, Governor Inslee expanded vaccine eligibility for some essential workers, and the Department of Health (DoH) updated their vaccine eligibility guidance and timing. However, the DoH is now reevaluating all guidance for Phases 2-4 while still trying to open vaccine eligibility to the public by May 1. Here’s where things stand:• Manufacturing workers, specifically, “those […]

  • Industry Reports
  • 2020

Life Science Market Report 2020

The life sciences industry has been thrust into the spotlight as the world faces its greatest public health crisis in a century. Investors have a heightened interest in the life sciences industry as it works to develop and distribute a vaccine and effective treatments for COVID-19, along with other medical breakthroughs. This, in turn, is […]